BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Ursodeoxycholic acid
1
Tumor necrosis factor alpha-induced protein 3: Biomarker discovery and therapeutic advancement in primary biliary cholangitis
11/27/2025 7:53:53 AM | Browse: 58 | Download: 189
2
Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies
10/11/2025 9:30:02 AM | Browse: 99 | Download: 370
3
MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid
8/18/2025 10:04:53 AM | Browse: 145 | Download: 565
4
Evolving therapeutic landscape of primary biliary cholangitis: A review
7/25/2025 12:09:40 PM | Browse: 111 | Download: 557
5
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation
12/26/2024 3:04:22 AM | Browse: 144 | Download: 578
6
Risk factors for recurrence of common bile duct stones after surgical treatment and effect of ursodeoxycholic acid intervention
1/25/2024 6:43:28 AM | Browse: 425 | Download: 1316
7
Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis
9/20/2023 4:48:37 PM | Browse: 259 | Download: 1110
8
Secondary bile acids and the biliary epithelia: The good and the bad
1/6/2023 2:52:58 AM | Browse: 440 | Download: 1025
9
Diagnosis and treatment of an inborn error of bile acid synthesis type 4: A case report
9/10/2021 7:23:16 AM | Browse: 669 | Download: 2056
10
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
3/11/2021 8:31:02 AM | Browse: 942 | Download: 2358
11
Idiopathic adulthood ductopenia with elevated transaminase only: A case report
12/19/2020 4:08:53 PM | Browse: 935 | Download: 2215
12
Low phospholipid-associated cholelithiasis syndrome: A rare cause of acute pancreatitis that should not be neglected
6/28/2020 7:49:11 AM | Browse: 1322 | Download: 2355
13
Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway
3/28/2019 9:14:40 AM | Browse: 1207 | Download: 2328
14
Δ4-3-oxosteroid-5β-reductase deficiency: Responses and long-term outcomes from oral bile acid therapy
2/21/2019 9:31:55 AM | Browse: 1022 | Download: 2513
15
Treatment of primary sclerosing cholangitis in children
1/27/2019 7:04:05 AM | Browse: 1368 | Download: 2067
16
Glutathione depleting drugs, antioxidants and intestinal calcium absorption
11/27/2018 5:55:53 AM | Browse: 1345 | Download: 2079
17
Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones
10/18/2018 10:13:24 AM | Browse: 1209 | Download: 2502
18
Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis
11/27/2017 2:36:57 AM | Browse: 1268 | Download: 2601
19
Oxidative stress, antioxidants and intestinal calcium absorption
4/28/2017 10:26:16 AM | Browse: 1341 | Download: 1877
20
Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
1/6/2017 8:51:00 AM | Browse: 1382 | Download: 2699
21
Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice
9/28/2015 11:46:00 AM | Browse: 1333 | Download: 2881
22
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy
5/13/2015 10:06:00 AM | Browse: 1389 | Download: 1967
23
Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed
9/15/2014 8:54:00 PM | Browse: 1321 | Download: 1275
24
Primary biliary cirrhosis and hereditary hemorrhagic telangiectasia: When two rare diseases coexist
9/10/2014 3:50:00 PM | Browse: 1292 | Download: 1643
25
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature
8/25/2014 5:12:00 PM | Browse: 1196 | Download: 1332
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.